Clinical Trial Update: Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dostarlimab for locally advanced or metastatic dMMR/MSI cancers excluding colorectal and endometrial, across multiple tumor types; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma
• Ampulla of Vater Carcinoma
• Duodenum Adenocarcinoma
• Gastric Adenocarcinoma
• Neuroendocrine Carcinoma
• Pancreatic Adenocarcinoma
• Small Bowel Adenocarcinoma
• Soft Tissue Sarcoma

Drugs mentioned

• Dostarlimab (dostarlimab)

Snippet

Sponsor: UNICANCER | Conditions: Pancreatic Adenocarcinoma, Ampulla of Vater Carcinoma | Phase 2 | Status: RECRUITING